Target has ended its relationship with celebrity chef Paula Deen following reports that she used racial slurs, according to published reports.
The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.
The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.
Canadian regulators have approved a drug for treating a condition that affects up to three-quarters of women and causes excessive bleeding from the uterus.
Takeda Pharmaceutical Co. is seeking Food and Drug Administration approval for an experimental treatment for inflammatory bowel disease, the drug maker said.
Mylan Specialty has appointed Roger Graham as president, the Mylan subsidiary said Monday.
Becton, Dickinson and Co. has launched a needle that it said would make insulin injections easier and faster for people with diabetes.
The Food and Drug Administration has approved a contraceptive pill for all women of childbearing potential without a prescription, the agency said.
Pharmaceutical wholesaler H.D. Smith will buy a majority interest in a Cincinnati-based patient assistance, pharmaceutical brand support and reimbursement company.
Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.
A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.
Target Corp. is reaching out to Canadian customers preparing to send their children to summer camp with information and resources about allergies.
Three new drugs for Type 2 diabetes made by Takeda Pharmaceutical have become available in pharmacies, the company said.
Avella Specialty Pharmacy will be included in the limited-distribution network for a cancer drug made by Genentech, Avella said Tuesday.
A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.
Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.
Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.
Drug maker Johnson & Johnson plans to spend up to $1 billion to acquire a privately owned company developing a drug for prostate cancer.
Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.
Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.
The Food and Drug Administration has approved a drug made by Amgen for treating a rare and usually noncancerous bone tumor, the agency said Thursday.
Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.
More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.
Walgreens on Wednesday reached an agreement settling DEA concerns relating to the distribution and dispensing of controlled substances.
Aceto Corp. will sell an authorized generic version of a drug used to treat a rare but devastating degenerative disorder.